[Cutaneous reactions secondary to anaesthetic induction with mivacurium].
Miloudi
Y
Y
El Harrar
N
N
Bensaid
A
A
Hussein
M A
MA
D000771:Anesthesia, Intravenous; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D001986:Bronchial Spasm / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005283:Fentanyl / Q000008:administration & dosage; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007262:Infusions, Intravenous; D007546:Isoquinolines / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D000077590:Mivacurium; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D013517:Otorhinolaryngologic Surgical Procedures; D011446:Prospective Studies; D012306:Risk; D012720:Severity of Illness Index; D013874:Thiopental / Q000008:administration & dosage; D013997:Time Factors; D014581:Urticaria / Q000139:chemically induced; D014673:Vecuronium Bromide / Q000008:administration & dosage / Q000009:adverse effects
D018686:Anesthetics, Intravenous; D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D000077590:Mivacurium; D014673:Vecuronium Bromide; D013874:Thiopental; D005283:Fentanyl